A1 Awadi FM, Gumaa KA. Studies on the activity of individual plants of an antidiabetic plant mixture. Acta Diabetol Lat 24.1 (1987): 37-41.
Allam AF, el Sayad MH, Khalil SS. Laboratory assessment of the molluscicidal activity of Commiphora molmol (Myrrh) on Biomphalaria alexandrina, Bulinus truncatus and Lymnaea cailliaudi. J Egypt Soc Parasitol 31.3 (2001): 683-90.
Andersson M et al. Minor components with smooth muscle relaxing properties from scented myrrh (Commiphora guidotti). Planta Med 63.3 (1997): 251-4.
Barakat R, Elm or she dy H, Fenwick A. Efficacy of myrrh in the treatment of human schistosomiasis mansoni. Am J Trop Med Hyg 73.2 (2005): 365-7.
Beers MH, Berkow R (eds). The Merck Manual of Diagnosis and Therapy, 17th edn; Rahway, NJ: Merck and C, 2003.
Blumenthal M, Goldberg A, Brinckmann J (eds). Herbal Medicine: Expanded Commission E Monographs. Austin, TX: Integrative Medicine Communications, 2000.
bo-Madyan AA, Morsy TA, Motawea SM. Efficacy of myrrh in the treatment of schistosomiasis (haematobium and mansoni) in Ezbet El-Bakly, Tamyia Center, El-Fayoum Governorate, Egypt. J Egypt Soc Parasit 34.2 (2004a): 423-46.
bo-Madyan AA, Morsy TA, Motawea SM, Morsy AT. Clinical trial of Mirazid in treatment of human fascioliasis, Ezbet El-Bakly (Tamyia Center) Al-Fayoum Governorate. J Egypt Soc Parasit 34.3 (2004b): 807-18.
Bordia A, Chuttani SK. Effect of gum guggulu on fibrinolysis and platelet adhesiveness in coronary heart disease. Indian J Med Res 70 (1979): 992-6.
Botros S et al. Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households. Am J Trop Med Hyg 72.2 (2005): 119-23.
Claeson P, Andersson R, Samuels son G. T-cadinol: a pharmacologically active constituent of scented myrrh: introductory pharmacological characterization and high field *H- and 13C-NMRdata. Planta Med 57.4 (1991): 352-6.
Dalvi S S et al. Effect of gugulipid on bioavailability of diltiazem and propranolol. J Assoc Physicians India 42.6 (1994): 454-5.
Dolara P et al. Local anaesthetic, antibacterial and antifungal properties of sesquiterpenes from myrrh. Planta Med 66.4 (2000): 356-8.
Gopal K et al. Clinical trial of ethyl acetate extract of gum gugulu (gugulipid) in primary hyperlipidemia. J Assoc Physicians India 34.4 (1986): 249-51.
Kimura I et al. New triterpenes, myrrhanol A and myrrhanone A, from guggul-gum resins, and their potent anti-inflammatory effect on adjuvant-induced air-pouch granuloma of mice. Bioorg Med Chem Lett 11.8 (2001): 985-9.
Kumar P, Clark M. Clinical Medicine, 5th edn. WB Saunders, 2002.
Malhotra SC, Ahuja MM, Sundaram KR. Long term clinical studies on the hypolipidaemic effect of Commiphora mukul (Guggulu) and clofibrate. Indian J Med Res 65.3 (1977): 390-5.
Massoud A et al. Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh). Am J Trop Med Hyg 65.2 (2001a): 96-9.
Massoud AM, Labib IM, Rady M. Biochemical changes of Culex pipiens larvae treated with oil and oleo-resin extracts of Myrrh Commiphora molmol. J Egypt Soc Parasitol 31.2 (2001b): 517-29.
Nityanand S, Srivastava JS, Asthana OP. Clinical trials with gugulipid: A new hypolipidaemic agent. J Assoc Physicians India 37.5 (1989): 323-8.
Saeed MA, Sabir AW. Antibacterial activities of some constituents from oleo-gum-resin of Commiphora mukul. Fitoterapia 75.2 (2004): 204-8.
Sharma JN, Sharma JN. Comparison of the anti-inflammatory activity of Commiphora mukul (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant. Arzneimittelforschung 27.7 (1977): 1455-7.
Sheir Z et al. A safe, effective, herbal antischistosomal therapy derived from myrrh. Am J Trop Med Hyg 65.6
Singh V et al. Stimulation of low density lipoprotein receptor activity in liver membrane of guggulsterone treated rats. Pharmacol Res 22.1 (1990): 37-44. Singh BB, Mishra LC, Vinjamury SP, Aquilina N, Singh VJ, Shepard N. The effectiveness of Commiphora mukul for osteoarthritis of the knee: An outcomes study. Altern Ther Health Med 9.3 (2003): 74-9. Szapary P et al. Guggulippid for the treatment of hypercholesterolemia. JAMA 290.6 (2003): 765-72. Thappa DM, DograJ. Nodulocystic acne: oral gugulipid versus tetracycline. J Dermatol 21.10 (1994): 729-31. Tipton DA, Lyle B, Babich H, Dabbous KH. In vitro cytotoxic and anti-inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells. Toxicol In Vitro 17.3 (2003): 301-10. Tipton DA, Hamman NR, Dabbous MK. Effect of myrrh oil on IL-lbeta stimulation of NF-kappaB activation and PGE(2) production in human gingival fibroblasts and epithelial cells. Toxicol In Vitro 20.2 (2005): 24855.
Ulbricht C et al. Guggal for hyperlipidemia: A review by the natural standard research collaboration.
Complement Ther Pract 13 (2005): 279-90. Urizar NL et al. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 296.5573
Wu J et al. The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor. Mol Endocrinol 16.7 (2002): 1590-7.
Was this article helpful?